This article provides a comprehensive guide to network meta-analysis (NMA) for drug development professionals and researchers.
This article provides a comprehensive guide to population-adjusted indirect comparison methods, particularly Matching-Adjusted Indirect Comparison (MAIC), for researchers and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on the critical process of identifying and justifying common comparators for Indirect Treatment Comparisons (ITCs).
This article provides a comprehensive guide for researchers and drug development professionals on formulating pivotal questions for Drug Comparative Effectiveness Research (CER).
This article provides a comprehensive guide to comparative drug efficacy research for drug development professionals and researchers.
This article provides a comprehensive overview of the foundational concepts and evolving landscape of pharmacoepidemiology for researchers and drug development professionals.
Network meta-analysis (NMA) has emerged as a powerful statistical methodology that enables simultaneous comparison of multiple interventions by combining direct and indirect evidence across a network of studies.
This article provides a comprehensive overview of mixed treatment comparison (MTC) models, also known as network meta-analysis, a powerful statistical methodology for comparing multiple interventions simultaneously by combining direct and...
This article explores the transformative role of Real-World Evidence (RWE) in evaluating drug comparative effectiveness for researchers and drug development professionals.
This article provides a comprehensive introduction to Adjusted Indirect Treatment Comparisons (ITCs), a critical methodology for comparative effectiveness research when head-to-head trials are unavailable.